Published on in Vol 24, No 6 (2022): June
![Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis](https://asset.jmir.pub/assets/0a0c5399d64390e907a1c17b73e94901.png 480w,https://asset.jmir.pub/assets/0a0c5399d64390e907a1c17b73e94901.png 960w,https://asset.jmir.pub/assets/0a0c5399d64390e907a1c17b73e94901.png 1920w,https://asset.jmir.pub/assets/0a0c5399d64390e907a1c17b73e94901.png 2500w)
1 Division of Pharmacoepidemiology and Clinical Pharmacology, University of Utrecht, Utrecht, Netherlands
2 Dutch Institute for Clinical Auditing, Leiden, Netherlands
3 Stichting Volksgezondheidszorg (VGZ), Arnhem, Netherlands
4 Dutch Association of Hospital Pharmacists, De Meern, Netherlands
5 Medicines Evaluation Board, Utrecht, Netherlands
6 Department of Medical Oncology, Amsterdam University Medical Center, location VUmc, Amsterdam, Netherlands
7 Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands
8 Rode Kruis Ziekenhuis, Beverwijk, Netherlands
*these authors contributed equally